𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A partially overlapping treatment course with lamivudine and interferon in hepatitis B e antigen-negative chronic hepatitis B

✍ Scribed by E. K. MANESIS; G. V. PAPATHEODORIDIS; S. J. HADZIYANNIS


Book ID
108604384
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
87 KB
Volume
23
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Efficacy of lamivudine in patients with
✍ Nicolaos C. Tassopoulos; Riccardo Volpes; Giuseppe Pastore; Jenny Heathcote; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ‫؍‬ 60

Natural course and response to interfero
✍ Maurizia Rossana Brunetto; Filippo Oliveri; Giuseppe Rocca; Domenico Criscuolo; 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

The course of chronic hepatitis B was studied in 30 patients who had antibody to hepatitis e antigen and hepatitis B virus DNA in the serum and hepatitis B core antigen in the liver. Over a 2-year period, no patient experienced a sustained spontaneous remission of disease, and follow-up liver histol